189 related articles for article (PubMed ID: 27266867)
1. The efficacy and safety of Fufangdanshen tablets (Radix Salviae miltiorrhizae formula tablets) for mild to moderate vascular dementia: a study protocol for a randomized controlled trial.
Tian J; Shi J; Wei M; Qin R; Ni J; Zhang X; Li T; Wang Y
Trials; 2016 Jun; 17(1):281. PubMed ID: 27266867
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of Tianmabianchunzhigan in mild to moderate vascular dementia: Protocol of a randomized controlled IIa trial.
Tian J; Shi J; Wei M; Li T; Ni J; Zhang X; Zhang M; Li Y; Wang Y
Medicine (Baltimore); 2018 Dec; 97(51):e13760. PubMed ID: 30572524
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for treating Alzheimer's disease: protocol for a randomized controlled trial.
Chua KK; Wong A; Kwan PW; Song JX; Chen LL; Chan AL; Lu JH; Mok V; Li M
Trials; 2015 Apr; 16():199. PubMed ID: 25925312
[TBL] [Abstract][Full Text] [Related]
4. Effects of Chinese medicine for promoting blood circulation and removing blood stasis in treating patients with mild to moderate vascular dementia: a randomized, double-blind and parallel-controlled trial.
Wei MQ; Tian JZ; Shi J; Ma FY; Miao YC; Wang YY
Zhong Xi Yi Jie He Xue Bao; 2012 Nov; 10(11):1240-6. PubMed ID: 23158942
[TBL] [Abstract][Full Text] [Related]
5. Rationale and design of a multicenter, phase 2 clinical trial to investigate the efficacy of traditional Chinese medicine SaiLuoTong in vascular dementia.
Liang J; Li F; Wei C; Song H; Wu L; Tang Y; Jia J
J Stroke Cerebrovasc Dis; 2014; 23(10):2626-2634. PubMed ID: 25294055
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of Shenmayizhi decoction as an adjuvant treatment for vascular dementia: Study protocol for a randomized controlled trial.
Wang H; Liu N; Wei Y; Pei H; Liu M; Diao X; Zhang H; Li H
Medicine (Baltimore); 2019 Dec; 98(50):e18326. PubMed ID: 31852125
[TBL] [Abstract][Full Text] [Related]
7. Donepezil in vascular dementia: combined analysis of two large-scale clinical trials.
Román GC; Wilkinson DG; Doody RS; Black SE; Salloway SP; Schindler RJ
Dement Geriatr Cogn Disord; 2005; 20(6):338-44. PubMed ID: 16192723
[TBL] [Abstract][Full Text] [Related]
8. Galantamine treatment of vascular dementia: a randomized trial.
Auchus AP; Brashear HR; Salloway S; Korczyn AD; De Deyn PP; Gassmann-Mayer C;
Neurology; 2007 Jul; 69(5):448-58. PubMed ID: 17664404
[TBL] [Abstract][Full Text] [Related]
9. Study protocol for a phase III randomised controlled trial of Sailuotong (SLT) for vascular dementia and Alzheimer's disease with cerebrovascular disease.
Karamacoska D; Chan DKY; Leung I; Liu JX; Brodaty H; Fahey PP; Bensoussan A; Chang DH
PLoS One; 2023; 18(3):e0265285. PubMed ID: 36920949
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Guilingji Capsules () for Treating Mild-to-Moderate Cognitive Impairment: Study Protocol for A Randomized, Double-Blind, Positive-Controlled, Multicenter and Noninferiority Trial.
Liu NY; Pei H; Liu MX; Liu LT; Fu CG; Li H; Chen KJ
Chin J Integr Med; 2020 Aug; 26(8):577-582. PubMed ID: 32761337
[TBL] [Abstract][Full Text] [Related]
11. The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A multicentre, randomized, double-blind, placebo-controlled trial.
Jia J; Wei C; Liang J; Zhou A; Zuo X; Song H; Wu L; Chen X; Chen S; Zhang J; Wu J; Wang K; Chu L; Peng D; Lv P; Guo H; Niu X; Chen Y; Dong W; Han X; Fang B; Peng M; Li D; Jia Q; Huang L
Alzheimers Dement; 2016 Feb; 12(2):89-99. PubMed ID: 26086183
[TBL] [Abstract][Full Text] [Related]
12. Combination of acupuncture and Chinese herbal formula for elderly adults with mild cognitive impairment: protocol for a randomized controlled trial.
Chen Y; Zhang W; Wu H; Lao L; Xu J; Xu S
Trials; 2019 Feb; 20(1):117. PubMed ID: 30744676
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300).
Orgogozo JM; Rigaud AS; Stöffler A; Möbius HJ; Forette F
Stroke; 2002 Jul; 33(7):1834-9. PubMed ID: 12105362
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
Black S; Román GC; Geldmacher DS; Salloway S; Hecker J; Burns A; Perdomo C; Kumar D; Pratt R;
Stroke; 2003 Oct; 34(10):2323-30. PubMed ID: 12970516
[TBL] [Abstract][Full Text] [Related]
15. Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial.
Guekht AB; Moessler H; Novak PH; Gusev EI;
J Stroke Cerebrovasc Dis; 2011; 20(4):310-8. PubMed ID: 20656516
[TBL] [Abstract][Full Text] [Related]
16. Cyclandelate in the treatment of patients with mild to moderate primary degenerative dementia of the Alzheimer type or vascular dementia: experience from a placebo controlled multi-center study.
Weyer G; Eul A; Milde K; Wierich W; Herrmann WM
Pharmacopsychiatry; 2000 May; 33(3):89-97. PubMed ID: 10855459
[TBL] [Abstract][Full Text] [Related]
17. Sanjin tablets for acute uncomplicated lower urinary tract infection (syndrome of dampness-heat in the lower jiao): protocol for randomized, double-blind, double-dummy, parallel control of positive drug, multicenter clinical trial.
Lyu J; Xie YM; Gao Z; Shen JW; Deng YY; Xiang ST; Gao WX; Zeng WT; Zhang CH; Yi DH; Wang LX; Wang ZF
Trials; 2019 Jul; 20(1):446. PubMed ID: 31324199
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).
Wilcock G; Möbius HJ; Stöffler A;
Int Clin Psychopharmacol; 2002 Nov; 17(6):297-305. PubMed ID: 12409683
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA;
Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
